Dura Incorporation – Trademark Portfolio

Entity Type: 03

Dura Incorporation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include DURA. The owner is based in San Ramon, CA.

2222 Camino Ramon

San Ramon, CA 94583

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DURA
DURA
Pending 2024
DURA
DURA
Registered 2022
DURA
DURA
Abandoned 2021

Trademark Classifications

Dura Incorporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Dura Incorporation have?

Dura Incorporation has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.

What trademark classes does Dura Incorporation file in?

Dura Incorporation files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Dura Incorporation's most well-known trademarks?

Dura Incorporation's registered trademark portfolio includes well-known marks such as DURA. These are among 1 currently registered trademark in the portfolio.

What is Dura Incorporation's trademark registration success rate?

Dura Incorporation has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.